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Individuals with neurofibromatosis type 1 (NF1)
develop abnormalities of both neuronal and
glial cell lineages, suggesting that the NF1 pro-
tein neurofibromin is an essential regulator of
neuroglial progenitor function. In this regard,
Nf1-deficient embryonic telencephalic neuro-
spheres exhibit increased self-renewal and pro-
longed survival as explants in vivo. Using
a newly developed brain lipid binding protein
(BLBP)-Cre mouse strain to study the role of
neurofibromin in neural progenitor cell function
in the intact animal, we now show that neuro-
glial progenitor Nf1 inactivation results in in-
creased glial lineage proliferation and abnormal
neuronal differentiation in vivo. Whereas the
glial cell lineage abnormalities are recapitulated
by activated Ras or Akt expression in vivo,
the neuronal abnormalities were Ras- and Akt
independent and reflected impaired cAMP gen-
eration in Nf1-deficient cells in vivo and in vitro.
Together, these findings demonstrate that
neurofibromin is required for normal glial and
neuronal development involving separable Ras-
dependent and cAMP-dependent mechanisms.
INTRODUCTION
Neurofibromatosis type 1 (NF1) is a common autosomal
dominant disorder in which affected individuals develop
abnormalities that involve both astrocytes and neurons.
In this regard, 20% of children and adults with NF1 de-
velop low-grade astrocytic tumors (gliomas) involving
the optic pathway (Listernick et al., 1999). In addition,
40%–60% of children with NF1 exhibit specific learning
disabilities with associated low IQ scores (Hyman et al.,
2005). Advanced neuroimaging and limited pathologic ex-
amination of the brains of affected children have failed toCelldiscern a structural basis for these cognitive abnormali-
ties.
The fact that both the astroglial and neuronal lineages
are affected in NF1 suggests that the NF1 gene product
neurofibromin may be important for neural stem cell
(NSC) or neuroglial progenitor cell function. Support for
this notion derives from previous experiments in our lab-
oratory demonstrating that Nf1-deficient embryonic tel-
encephalic NSCs exhibited dramatic increases in self-
renewal and proliferation (Dasgupta and Gutmann,
2005). Similarly, others have found increased numbers of
progenitor cells in the spinal cords from Nf1/embryos
(Bennett et al., 2003). In addition, Nf1/ embryos often
display a variety of neural tube defects such as exence-
phaly or thinning of the dorsal telencephalic wall (Lakkis
et al., 1999). Using the human GFAP promoter to condi-
tionally inactivate the Nf1 gene, neurofibromin loss start-
ing between embryonic day (E) 10.5 and E12.5 results in
abnormal neurological behaviors and hyperproliferation
of glial progenitors (Zhu et al., 2005), whereas neurofibro-
min loss starting at E14.5 results only in increased astro-
cyte proliferation (Bajenaru et al., 2002). In contrast, Nf1
inactivation in a differentiated neuronal population using
Synapsin 1 conditional Nf1 inactivation results in reduced
neocortical thickness, less apparent forebrain cortical
lamination, and increased cell density (Zhu et al., 2001).
The NF1 gene encodes a large cytoplasmic protein,
neurofibromin, which primarily functions as a negative
regulator of the Ras proto-oncogene (DeClue et al.,
1992). Loss or reduced neurofibromin expression leads
to increased Ras activity as a result of impaired neuro-
fibromin GTPase activating protein (GAP) function. Hyper-
activation of the Ras signaling pathway has also been as-
sociated with increased mammalian target of rapamycin
(mTOR) activity in astrocytes and Schwann cells (Das-
gupta et al., 2005; Johannessen et al., 2005). In addition
to its ability to inhibit Ras and mTOR activity, neurofibro-
min is required for intracellular cyclic AMP (cAMP) gener-
ation in both neurons and astrocytes (Dasgupta et al.,
2003; Tong et al., 2002). In mammalian cells, it is not clear
what NF1 disease phenotypes relate to deregulated
cAMP generation, prompting recent speculation basedStem Cell 1, 443–457, October 2007 ª2007 Elsevier Inc. 443
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Nf1 Regulates Neuroglial Progenitor FunctionFigure 1. Characterization of BLBP-Cre Transgenic Mice
(A) Schematic of the BLBP-Cre targeting construct.
(B) lacZ expression appears by E9.5 in the spinal cord and hindbrain. From E10.5, lacZ expression is located in the midbrain and rostral forebrain.
By E12.5, lacZ expression further extends throughout telencephalon.
(C) Cre expression is restricted to BLBP+ ventricular zone cells in the developing nervous system at E10.5.
(D) E14.5 BLBP+ embryonic neural stem cells exhibit Cre expression in vitro.444 Cell Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inc.
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not have separable Ras and cAMP functions (Walker
et al., 2006).
To better define the role of neurofibromin in the devel-
oping brain and to determine whether neurofibromin has
distinct Ras and cAMP functions in the central nervous
system (CNS), we chose to inactivate the Nf1 gene in em-
bryonic neuroglial progenitors. We chose to target brain
lipid binding protein (BLBP or Fabp7)-expressing cells in
the nervous system based on numerous lines of evidence
that suggest that BLBP is expressed in cells with the ca-
pacity for self-renewal and multilineage differentiation.
BLBP is robustly expressed in the major adult neurogenic
regions, including in the subventricular zone (Sundholm-
Peters et al., 2004), spinal cord (Taylor et al., 2005), and
germinal layer of the dentate gyrus (Kurtz et al., 1994).
Moreover, BLBP expression is found in embryonic and
adult NSC neurosphere cultures capable of self-renewal
and multilineage differentiation (Dromard et al., 2006).
Based on these observations, we generated transgenic
mice that express Cre recombinase under the control of
a fragment of the mouse BLBP promoter (Arnold et al.,
1994).
In this study, we show that loss of neurofibromin in
BLBP+ cells in vivo results in increased proliferation of
neuroglial progenitor cells during embryogenesis and
leads to an expansion of glial progenitors as well as ma-
ture astrocytes in a Ras- and Akt-dependent fashion. In
addition, neurofibromin is necessary for normal neuronal
differentiation and forebrain cortical development, which
reflects the ability of neurofibromin to positively regulate
intracellular cAMP levels. This unique Nf1 mouse model
provides a valuable tool to study the neuronal and glial
abnormalities associated with the human disease and to
define how defects in Ras and cAMP signaling regulate
progenitor cell differentiation in vivo.
RESULTS
Development and Characterization of BLBP-Cre
Transgenic Mice
In order to inactivate the Nf1 gene in embryonic neuro-
glial progenitor cells, mice were generated that express
nuclear-targeted Cre recombinase under the control of
a 1.6 kb fragment of the mouse BLBP promoter (Arnold
et al., 1994). This expression construct also contains an
IRES-lacZ sequence to allow for detection of BLBP pro-
moter activity in the developing embryo by X-gal staining
(Figure 1A). Three independent founders were identified
by PCR and used to establish BLBP-Cre transgenic lines.
Analysis of lacZ activity in the resulting embryos and adult
mice showed that lines #2 and #3 displayed identicalCelspatiotemporal expression patterns. These two lines
were used interchangeably in the present study.
We employed several methods to characterize Cre ex-
pression and activity in the nervous system of BLBP-
Cre mice. First, b-galactosidase expression was detected
along the ventricular region of the spinal cord and in the
hindbrain by E9.5. At E10.5, lacZ activity appeared in
the dorsal portion of the rostral neuroepithelium and in
the midbrain. By E12.5, the b-galactosidase activity ex-
tended into the ventricular/subventricular regions of the
brain (Figure 1B). No lacZ activity was found in any other
organ system. In young adult mice, lacZ activity was
detected in the ependymal cell layer of the ventricle with
distinct cellular labeling in the subventricular zones as
well as in the subgranular zone of the dentate gyrus
(data not shown). Second, to demonstrate that Cre re-
combinase expression was detected in embryonic cells
with endogenous BLBP expression, we labeled BLBP-
and Cre-expressing cell populations in transverse sec-
tions of the neural tube by immunofluorescence. Trans-
genic Cre expression was coincident with endogenous
BLBP expression in the ventricular region (Figure 1C).
Third, to demonstrate that Cre recombinase was ex-
pressed in neuroglial progenitor cells, we generated neu-
rospheres from BLBP-Cre embryos (E12.5 and E14.5) and
neonatal mice. As in the intact embryonic ventricular zone,
both endogenous BLBP and transgenic Cre recombinase
expression were detected in embryonic and postnatal
neurospheres (Figure 1D and Figures S1A and S1B in
the Supplemental Data available with this article online)
that were capable of self-renewal (data not shown) and
multilineage differentiation (Figure S1C). Fourth, we ana-
lyzed Cre recombinase expression in BLBP-Cre mice
by immunofluorescence at postnatal day 18 (PN18). No
GFAP+ astrocytes or NeuN+ neurons contained Cre+ nu-
clei. However, > 90% of Cre+ cells expressed BLBP
(Figure 1E). Finally, to assess Cre recombinase activity,
we crossed BLBP-Cre mice with the R26R-EYFP reporter
strain (Srinivas et al., 2001). At PN18, the majority of APC+
oligodendrocytes in the fimbria, GFAP+ astrocytes in the
CA1 region of the hippocampus, and NeuN+ neurons in
the cortex were colabeled by an antibody against EYFP
(Figure 1F). No EYFP expression was detected outside
of the nervous system. Collectively, these results demon-
strate that Cre recombinase is expressed in BLBP+ cells in
the embryonic (and adult) ventricular zone capable of self-
renewal and multilineage differentiation.
Generation of Nf1 Conditional Knockout Mice
In order to evaluate the role of neurofibromin in the
developing CNS, BLBP-Cre mice were intercrossed
with Nf1flox/flox mice (Zhu et al., 2001). BLBP-Cre;(E) At PN18, only BLBP+ progenitor cells express Cre recombinase (arrowheads) in the subventricular zone. No Cre recombinase expression was
present in GFAP+ cells (astroglial) in the hippocampus or in cortical NeuN+ cells (neurons).
(F) EYFP expression is present in all major cell types of the brain, including APC+ oligodendrocytes from the fimbria, GFAP+ astrocytes in the
hippocampus, and NeuN+ neurons of the cortex of R26R-EYFP 3 BLBP-Cre mice (indicated by arrowheads).
Scale bars: (C), 250 mm; (D), 100 mm; (E), 50 mm; and (F), 25 mm.l Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inc. 445
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Nf1 Regulates Neuroglial Progenitor FunctionFigure 2. Neurofibromin Loss in the Brain Results in Dwarfism and Premature Death
(A) CKO mice have a median survival of 18 days.
(B) Growth retardation appears within 7 days after birth. Values represent mean and standard error of measurement (SEM).
(C) Significant weight reduction of the heart and liver was observed, while the slight reduction in brain weight was not statistically significant. Error bars
denote SEM.
(D)Neurofibrominexpressionwasdecreased in thecortexandhippocampusofCKOmiceby immunohistochemistryandwesternblot.Scalebar,100mm.
(E) Increased activation of Akt and Erk1/2, but not S6, was detected. Asterisks denote a statistically significant difference (p < 0.05).Nf1flox/wt 3 Nf1flox/flox crossings resulted in progeny with
the expected Mendelian ratios in utero and at birth.
BLBP-Cre; Nf1flox/flox (CKO), BLBP-Cre; Nf1flox/wt (HET),
as well as BLBP-Cre, Nf1flox/flox and Nf1flox/wt (WT) mice
were indistinguishable by appearance at PN1. However,
CKO mice developed progressive growth retardation
from PN3 and the majority of the pups failed to survive
to weaning. CKO mice displayed limited range of move-
ment of the rear legs and an extreme sensitivity to han-
dling. Brain electric activity was monitored by implanted
electrodes during a 24 hr observation period and no sei-446 Cell Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inczures were observed (M. Wong, personal communica-
tion). Median survival for CKO mice was 18 days, and no
mice survived longer than 3 months (Figure 2A). At
PN18, the weight of the surviving CKO mice was less
than 50% that of their control littermates (Figure 2B). All
the major organ systems displayed growth retardation,
except for the CNS. Eighteen days after birth, we found
a significant decrease in the weight of the heart and liver
(Figure 2C), as well as of the spleen, kidney, and testis
(data not shown). However, complete autopsy and histo-
logical analysis of two representative PN18 CKO mice.
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in these organs (data not shown). There was a 7% reduc-
tion in the weight of CKO brains at PN18, which was not
statistically significant (p = 0.08). The exact cause of death
is not known.
Loss of neurofibromin expression in CKO brains was
demonstrated by immunohistochemistry (Figure 2D) at
PN18 as well as by western blotting of forebrain lysates
from newborn mice (Figure 2E). Because neurofibromin
is a major regulator of Ras, the activation of Ras down-
stream targets wasmeasured. In agreement with previous
studies, we found gene dose dependent increased
activation of Akt and ERK1/2 with activation-specific
antibodies (Figure 2E). In contrast, we observed no hy-
peractivation of the mTOR downstream target S6. Im-
munohistochemistry with phospho-specific S6 antibodies
showed no differences between CKO and wild-type (WT)
mice (Figure S2A), whereas there were increased numbers
of phospho-Erk1/2-labeled cortical pyramidal neurons in
CKO compared to WT brains (Figure S2B).
Increased Glial Cell Populations in CKO Mice
To evaluate the effect of neurofibromin loss in embryonic
neuroglial progenitor cells on multilineage differentiation,
immunohistochemical labeling for neuronal, astroglial,
and oligodendroglial markers was performed at PN18.
All major anatomical regions in the forebrain appeared
normal as demonstrated by the number of NeuN+ neu-
rons, the presence of MAP2+ neuronal processes, as
well as the extent of myelin basic protein (MBP) expres-
sion by oligodendrocytes (Figure 3A). However, we
observed increased numbers of GFAP+ astrocytes and
NG2+ glial cells as well as APC+ oligodendroglial cells in
the CKO brains (Figure 3B). We quantified the number of
GFAP+ cells in high-power fields of the CA1 region of
the hippocampus and found a significant Nf1 gene
dose-dependent increase in CKO and HET brains com-
pared to WT brains. Similarly, the number of APC+ cells
in the fimbria as well as the number of NG2+ cells in the
somatosensory cortex was significantly higher in the
CKO mice. The number of NG2+ cells was higher in HET
mice compared to wild-type animals; however, this in-
crease was not statistically significant (p = 0.1). There
was no difference in the number of NeuN+ cells in the pri-
mary somatosensory cortex or in the granular cell layer of
the hippocampus between CKO and WT mice (data not
shown). These findings demonstrate that loss of neurofi-
bromin in the neuroglial progenitor cells in vivo leads to
an expansion of glial, but not neuronal, cell populations.
We next sought to determine whether BLBP-mediated
Nf1 loss results in increased proliferation of neuroglial pro-
genitor cell populations in vivo. For these experiments,
timed-pregnant mice were injected with bromodeoxyuri-
dine (BrdU) 1 hr prior to euthanasia at E13.5 and E17.5.
Frozen sections of embryonic brains were labeled for
BrdU and markers of neuroglial and neuronal progenitors
(Figure 4A). Increased BrdU incorporation was observed
in the ventricular zone of CKO embryos at E13.5 and to
a lesser extent at E17.5. Almost all BrdU incorporatingCecell in the embryonic ventricular zone expressed Sox2,
a marker of proliferating neuroglial progenitor cells (Fig-
ure S3A). We also found increased numbers of Sox2+
and vimentin+ (neural stem cell/progenitor marker) cells
around the lateral ventricles of E13.5 CKO embryos. How-
ever, there was no difference in the thickness of the cor-
tical plate between CKO and WT mice using the neu-
ronal precursor markers Tuj1 and doublecortin (data not
shown). Postnatally, therewas no difference in the number
of BrdU+ or Sox2+ cells in the dentate gyrus and the sub-
ventricular zone (SVZ) of the lateral ventricles where adult
neural stem cells reside (Figure 4A and Figure S3B).
Previous studies have shown that neurofibromin regu-
lates proliferation in the brain (Zhu et al., 2005). To deter-
mine whether Nf1 inactivation in neuroglial progenitors
resulted in increased cell proliferation in the postnatal pe-
riod, we analyzed proliferation in 1-week-oldmice injected
with BrdU. We found increased numbers of proliferating
cells in the CA2/3 region of the hippocampus in both
HET and CKO mice compared to WT animals. Using anti-
bodies against BLBP and Olig2, a major transcription fac-
tor regulating glial differentiation (Ligon et al., 2006), we
observed increased numbers of Olig2+ glial and BLBP+
neuroglial progenitors throughout the brains of CKO
mice (Figures 4B and 4C). However, after normalization
to the total Olig2+ (or BLBP+) progenitor cell number,
there was no increase in the percentage of proliferating
Olig2+ (or BLBP+) cells, indicating that the increased
proliferation reflects an increase in the total number of
progenitor cells resulting from Nf1 loss. Consistent with
previous studies on Nf1/ astrocytes (Bajenaru et al.,
2002), astroglial cultures established from PN1 CKO
mice exhibited increased proliferation by BrdU and [3H]-
thymidine incorporation (Figure S3C). No difference in
the number of apoptotic cells labeled by activated cas-
pase-3 immunostaining or TUNEL staining was seen
(data not shown). Collectively, these data demonstrate
that neurofibromin expression in neuroglial progenitors
is required for proper glial cell differentiation and
proliferation.
Loss of Neurofibromin Results in Abnormal
Neurite Development
Because previous studies using Synapsin 1 conditional
Nf1 knockout mice implicated neurofibromin in cortical
development, we analyzed the brains of PN18 CKO mice
for defects in neuronal maturation. Using Golgi staining,
we found grossly normal organization of neuronal pro-
cesses in the brains of CKO mice (Figure 5A). However,
the apical dendrites of the layer II/III pyramidal neurons
in the somatosensory cortex were shorter in CKO com-
pared to WT or HET animals (Figure 5B). Interestingly,
when embryonic (E10.5) Nf1/ neurospheres undergo
neuronal differentiation in vitro, the resulting neurons
also exhibited shortened neurite processes (Figure 5C).
In contrast to the results obtained in vivo, there was a
gene dose-dependent decrease of neurite length in
Nf1+/ and Nf1/ differentiated NSC cultures in vitro
(Figure 5D).ll Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inc. 447
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Nf1 Regulates Neuroglial Progenitor FunctionFigure 3. CKO Brains Display Proper Anatomical Organization but Exhibit Increased Numbers of Glial Cells
(A) Coronal brain sections reveal a normal abundance of NeuN+ neurons, MAP2+ neuronal processes, and myelin basic protein (MBP).
(B) In CKOmice, increased density of GFAP+ cells was found in the CA1 region of hippocampus. HET exhibited an intermediate increase in cell den-
sity. The number of oligodendrocytes was also significantly higher in the high-power fields of coronal sections of fimbria of CKObrain compared toWT
or HET mice. The density of cortical NG2+ glial cells was increased in the CKO mice. Values represent mean ± SEM.
Scale bars: (A), 1 mm; (B), 100 mm. Asterisks denote a statistically significant difference (p < 0.05).Based on these observations, we hypothesized that
there might be a delay in cortical neuron maturation. To
better characterize this defect, we examined markers
associated with neuritogenesis and dendritic develop-
ment at PN1. We found decreased numbers of thick fi-
bers labeled by antibodies against MAP2, a microtubule-
associated protein found in dendrites (Figure 5E). There
was also reduced expression of GAP43, a developmen-
tally regulated growth cone-associated protein in the
developing cortex of CKO mice by immunofluorescence448 Cell Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inlabeling (Figure 5E) as well as by western blot (Figure 5F).
We also observed decreased expression of a phosphory-
lated form of the neurofilament heavy chain that is nor-
mally increased during neuronal differentiation (Figure 5F).
In contrast, we found no differences in the expression of
themajor proteins associated with presynaptic structures,
including synapsin 1 or synaptophysin (Figure 5F). Taken
together, these findings suggest that neurofibromin is
necessary for the normal development and differentiation
of neocortical neurons.c.
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Nf1 Regulates Neuroglial Progenitor FunctionFigure 4. Embryonic Loss of Neurofibromin Results in Increased Neuroglial Progenitor Cell Numbers
(A) Increased BrdU incorporation as well as increased numbers of Sox2+ and vimentin+ cells were observed in CKO brains at E13.5. There was no
difference in the pattern of Tuj1 labeling in the cortical plate.
(B) At PN8, increased numbers of Olig2+ glial progenitor cells were found throughout the brain (HC, hippocampus). There was an increase in prolif-
erating cells in the same region; however, no differences were found in the ratio of proliferating (BrdU+), Olig2+ cells in CKO andHET brains compared
to WT mice. Values represent mean ± SEM.
(C) A number of the proliferating cells expressed the progenitor marker BLBP.
Scale bars: (A), 100 mm; (B), 50 mm. Asterisks denote a statistically significant difference (p < 0.05). Arrowheads show double-labeled cells.Abnormal Glial, but Not Neuronal, Phenotypes
in CKO Mice Reflect Ras Activation
The major function of neurofibromin is to negatively regu-
late Ras activity. To recapitulate Ras activation resulting
from neurofibromin loss in neuroglial progenitor cells,Cewe employed LSL-KRasG12D mice (Johnson et al., 2001).
For these studies, BLBP-Cre and Lox-stop-lox (LSL)-
KRasG12D mice were intercrossed to generate BLBP-
Cre; LSL-KRasG12D (Kras*) mice. Kras* were viable
and lacked the severe growth retardation, abnormalll Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inc. 449
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Nf1 Regulates Neuroglial Progenitor FunctionFigure 5. Loss of Neurofibromin in Neuroglial Progenitor Cells Impairs Neuronal Differentiation
(A and B) Golgi staining of brains at PN18 demonstrated that the apical dendrites of pyramidal neurons were significantly shorter in CKO mice com-
pared to WT or HET animals.
(C and D)Nf1/ andNf1+/ embryonic NSCs stimulated to undergo differentiation in vitro generated neurons with significantly shorter Tuj1+ neurites.
(E) Decreased number of thick MAP2+ processes and less intense GAP43 staining was apparent in the cortex of PN1 CKO pups.
(F) Western blot analysis demonstrates reduced expression of phospho-neurofilament and GAP43 in PN1 brain lysates. No changes in synapsin 1 or
synaptophysin were seen.
Scale bars: (A), 25 mm; (C), 30 mm; and (E), 100 mm. Asterisks denote a statistically significant difference (p < 0.05).behaviors, or reduced survival observed in the CKO mice
(Figure 6A). Histological analysis of Kras* brains revealed
an expansion of glial cell populations similar to that ob-450 Cell Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Incserved in CKO mice, with more GFAP+ and NG2+ glial
cells and Olig2+ progenitor cells compared to WT mice
(Figure 6B and Figure S4A). Similar to CKO mice, there.
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Nf1 Regulates Neuroglial Progenitor FunctionFigure 6. Increased Glial Progenitor Numbers, but Not Neo-
cortical Neuronal Development, Is Kras- and Akt Dependent
(A) BLBP-Cre; LSL-KRasG12D (Kras*) and BLBP-Cre; LSL-myr-Akt
(Akt*) mice develop normally, and their brain weights are similar to
WT mice. There is a slight decrease in Kras* and Akt* body weights
at PN18 (p = 0.01).
(B) The number of NG2+ and GFAP+ cells is significantly higher in the
cortex and hippocampus of Kras* and Akt* mice, respectively.
(C) There is an increase in the number of BrdU incorporating as well as
Olig2+ cells in the hippocampus.
(D) Kras activation results in Erk1/2 and Akt activation but did not
change the expression of proteins involved in neuronal development
(synapsin I and GAP43). In the Akt* mice, there was abundant expres-
sion of the constitutively active form of Akt but there was no increase in
the activation status of Erk1/2 and S6.
Asterisks denote a statistically significant difference (p < 0.05). Values
represent mean ± SEM.Cewere also more BrdU+ cells in the CA2/3 region of Kras*
mice than in littermate controls (Figure 6C). However,
Golgi staining of Kras* brains did not demonstrate any
changes in pyramidal neuron apical dendrite lengths
(Figure S4B). Moreover, we did not observe any changes
in the expression of markers associated with neuritic de-
velopment (Figure 6D) or reduced forebrain cortical thick-
ness (Figure 7C) in Kras* mice.
One major downstream target of Ras is Akt. In order to
determine whether the brain abnormalities observed in the
CKO or Kras* mice could be recapitulated by constitutive
Akt activation, we generated BLBP-Cre; LSL-myr-Akt
(Akt*) mice. Similar to Kras* mice, Akt* mice were viable
and did not exhibit severe growth retardation, abnormal
behaviors, or reduced survival. Akt* mice had more
GFAP+ and NG2+ glial cells and Olig2+ progenitor cells
compared to WT mice (Figure 6B) as well as increased
numbers of BrdU+ cells in the CA2/3 region (Figure 6C).
Moreover, Akt* mice had normal forebrain cortical thick-
ness (Figure 7C). Interestingly, similar to CKO mice, Kras*
and Akt* mice did not exhibit increased S6 activation in
the brain (Figure 6D).
Collectively, these results demonstrate that constitutive
activation of Kras or Akt recapitulates the glial cell defects
associated with neurofibromin loss in neuroglial progeni-
tors but does not account for the abnormalities in neuronal
differentiation observed in CKO mice.
Neurofibromin Regulates Cortical Development
in a cAMP-Dependent Manner
Previous studies have shown that, in addition to its ability
to negatively regulate Ras, neurofibromin positively con-
trols cAMP generation in astrocytes and neurons (Das-
gupta et al., 2003; Tong et al., 2002). The inability of
Kras or Akt activation to recapitulate the neuronal defects
observed in CKOmice raised the intriguing possibility that
neurofibromin cAMP regulation may underlie the abnor-
malities in neuronal differentiation. In support of cAMP-
dependent effects, we found a significant decrease in
the total levels of intracellular cAMP in CKO brains
(Figure 7A). This reduction in cAMP levels was reflected
in reduced CREB activation in CKO, but not HET or WT,
mouse brains (Figure 7B and Figure S5A). No decrease
in CREB activity was seen in Kras* or Akt* mouse brains.
To investigate whether neurofibromin regulates fore-
brain cortical development and neurite length in a cAMP-
dependent manner, we employed a specific inhibitor of
phosphodiesterase-4 (PDE4) to increase cAMP levels
in vivo. Rolipram acts to inhibit PDE4-mediated deg-
radation of cAMP and has been used to elevate cAMP
in the CNS (Barad et al., 1998; Giorgi et al., 2004). Pre-
vious studies have shown that the thickness of the sec-
ondary somatosensory cortex is markedly reduced in
mice lacking neurofibromin in neurons (Zhu et al., 2001).
As reported for the Nf1SynICKO mice, the distance be-
tween the corpus callosum and the brain surface in the
secondary somatosensory cortex was significantly re-
duced in CKO mice. Rolipram was administered daily by
intraperitoneal injection from E11.5 to PN18 to the motherll Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inc. 451
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(A) Cyclic AMP levels were lower in CKO compared to WT brains (p = 0.02). Rolipram administration increased cAMP levels in CKO brains. Error bars
denote SEM.
(B) Activation of CREB was decreased in CKO, but not in HET, Kras*, or Akt* mice compared to WT controls.
(C) The thickness of the somatosensory cortex of CKOmice was reduced compared toWTmice. Rolipram treatment restored the cortical thickness in
CKO mice (CKO+R) to that seen in WT mice. Values represent mean ± SEM.
(D) Impaired neurite extension in differentiating CKO neural progenitors (p < 0.0001, arrowheads show cells with short neurites) was partially rescued
by rolipram treatment (p = 0.04 compared to untreated CKO cells; p = 0.014 compared to WT cells), whereas forskolin nearly completely rescued the452 Cell Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inc.
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resulting mice were euthanized at PN18. Rolipram-
treated, but not untreated, mice exhibited cortical thick-
ness similar to that observed in wild-typemice (Figure 7C).
Furthermore, Golgi staining revealed that rolipram treat-
ment partially restored the length of cortical pyramidal
neuron apical dendrites in the somatosensory cortex of
CKO mice to that seen in wild-type animals (Figure S6C).
Importantly, rolipram-treated CKO mice exhibited similar
increases in Akt and ERK activation as well as glial cell
expansion compared to untreated mice (Figures S5D
and S5E).
In order to demonstrate that impaired cAMP generation
in CKO mice accounted for the defects in neurite length,
we quantified neurite lengths of neurons generated from
E14.5 secondary neurospheres in vitro. After 7 days, we
observed a significant decrease in maximal neurite length
in CKO compared to WT neurons (p < 0.0001; Figure 7D).
In contrast, neurite lengths in Kras* or Akt* (data not
shown) neurosphere-derived neurons were indistinguish-
able from WT cultures. Next, we treated cultures with ei-
ther rolipram or forskolin to increase intracellular cAMP
levels. We found that rolipram treatment (20 mM) partially
restored the CKO neurite growth defect (p = 0.04 com-
pared to untreated CKO cells; p = 0.014 compared to
WT cells), whereas forskolin treatment (20 mM) nearly
completely rescued this defect in vitro (p = 0.003 com-
pared to untreated CKO cells; p = 0.28 compared to WT
cells). No effect of rolipram or forskolin was seen on WT
cultures. Collectively, these results demonstrate that
neurofibromin regulates neuronal development in a
cAMP-dependent and Ras-independent manner.
DISCUSSION
This study demonstrates an essential role for theNf1 gene
in neural progenitor cell function, astroglial growth regula-
tion, and neuronal differentiation. In CKO mice, we found
increased numbers of glial progenitors as well as mature
astrocytes and oligodendrocytes. These results are con-
sistent with previous studies from our laboratory in which
Nf1 inactivation in glial progenitors at E14.5 leads to in-
creased astrocyte proliferation in vitro and in vivo (Baje-
naru et al., 2002). Similarly, glial progenitorNf1 inactivation
between E10.5 and E12.5 results in increased numbers of
immature GFAP+/nestin+ cells as well as increased num-
bers of proliferating GFAP+ cells in vivo (Zhu et al., 2005).
It is important to note that the increased proliferation
observed postnatally is the result of the increased spec-
ification of glial progenitors rather than the increased
rate of glial progenitor proliferation (e.g., due to shortened
cell-cycle length, etc.). This observation suggests that
neurofibromin regulates neural stem/progenitor cell diff-
erentiation. It is likely that neurofibromin is an importantCeldeterminant of stem cell/progenitor cell self-renewal and
differentiation, such that Nf1 loss results in an inappropri-
ate persistence of immature progenitors in the brain. In
keeping with the cancer stem cell hypothesis (Singh
et al., 2004), this delay in glial progenitor maturation could
predispose to the development of glial cell tumors. In this
regard, preliminary analysis of the limited number of mice
that survived to 2–3 months of age indicates that Nf1 loss
in BLBP+ progenitor cells leads to cellular changes in the
prechiasmatic optic nerve suggestive of neoplasia.
Neurofibromin is also involved in the regulation of oligo-
dendrocyte precursor cells in the embryonicNf1/ spinal
cord (Bennett et al., 2003). We previously reported
increased oligodendrocyte numbers upon Nf1/ NSC
differentiation in vitro (Dasgupta and Gutmann, 2005). In
the current study, we also observed increased numbers
of APC+ cells in CKO mice, supporting the observation
that Nf1 loss impairs both astrocyte and oligodendrocyte
differentiation. However, we did not observe a statistically
significant gene dose effect of Nf1 loss in NG2+ glial cells,
APC+ oligodendrocytes, or Olig2+ glial progenitors.
These findings suggest that astrocytes may be most sen-
sitive to changes inNf1 gene expression and may underlie
the increased frequency of GFAP+ astrocytic tumors in
individuals with NF1.
The high incidence of cognitive dysfunction in NF1 pa-
tients suggests that neurofibromin is also necessary for
normal neuronal development. Importantly, Nf1+/ mice
exhibit learning deficits (Silva et al., 1997), whereas com-
plete loss of Nf1 in certain neuronal cell populations leads
to severe behavioral abnormalities (Zhu et al., 2005). The
impact of Nf1 loss on neuronal development was first
described in Nf1/ embryos that displayed hyperplasia
of neural crest-derived para- and prevertebral ganglia
(Brannan et al., 1994). In vitro, Nf1/ embryonic periph-
eral neuronal cell cultures exhibited nerve growth factor
(NGF)-independent survival (Klesse and Parada, 1998;
Vogel et al., 1995). Using Synapsin I to target Nf1 inactiva-
tion to neurons, neurofibromin loss resulted in increased
plasticity following peripheral nerve injury (Romero et al.,
2007).
However, in the CNS, neurofibromin loss in these same
Nf1SynICKO mice resulted in decreased cortical thickness
without any change in the number of cortical neurons (Zhu
et al., 2001), similar to Nf1BLBPCKO mice. In addition, we
found that Nf1 loss in neural stem/progenitor cells also
impairs apical dendrite length in vivo and neurite extension
in vitro. Consistent with decreased neurite length,we found
reduced expression of proteins involved in neuronal pro-
cess development, such as phosphorylated neurofilament
and GAP43 (Jacobson et al., 1986; Shea et al., 1997). The
decrease in GAP43 expression is interesting in light of the
established role of this protein in neuronal plasticity (Beno-
witz and Routtenberg, 1997), suggesting a role in memoryneurite length deficit (p = 0.003 compared to untreated CKO cells; p = 0.28 compared to WT cells). Neurite lengths in cells cultured from Kras* em-
bryos were indistinguishable from WT cultures. Error bars denote standard deviation.
Scale bars: (C), 100 mm; (D), 20 mm. Asterisks in (A) and (C) denote a statistically significant difference (p < 0.05).l Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Inc. 453
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NF1 patients and Nf1+/ mice.
Neurofibromin is a major regulator of Ras-dependent
signaling by virtue of its ability to stimulate the conversion
of the GTP-bound active Ras to the GDP-bound inactive
form (Basu et al., 1992; DeClue et al., 1992). To define
the mechanism underlying neurofibromin regulation of
neuroglial progenitor function, we used two approaches.
The first approach involved the use of mice with BLBP+
cell expression of an activated Kras or Akt allele. Kras hy-
peractivation, similar to constitutive activation of Akt, in
neuroglial progenitors in vivo recapitulated the glial cell
phenotypes observed in CKO mice, but not the neuronal
abnormalities. Second, we attempted to rescue the glial
cell defects in CKOmice in vivo by using rolipram to block
phosphodiesterase-4 (PDE4)-mediated cAMP degrada-
tion and increase intracellular cAMP levels. However, we
did not observe restoration of glial cell numbers or prolif-
eration after rolipram treatment. These findings suggest
that neurofibromin regulates gliogenesis from progenitor
cells in a Ras- and Akt-dependent, but cAMP-indepen-
dent, manner.
Another important downstream target of Ras is mTOR,
a major regulator of protein synthesis, previously shown
by ourselves and others to be hyperactivated inNf1/ as-
trocytes and Schwann cells (Dasgupta et al., 2005; Johan-
nessen et al., 2005). In contrast to differentiated glia, we
observed no change in mTOR pathway activation in
CKO mice. Collectively, these results demonstrate that
neurofibromin regulates gliogenesis in a Ras-dependent,
but mTOR-independent, fashion and suggest that the var-
ious downstream Ras effectors have cell type-specific
roles in the developing CNS.
Whereas activated Kras or Akt expression in BLBP+
cells recapitulated the glial phenotypes seen in CKO
mice, constitutive activation of Kras or Akt did not affect
forebrain cortical thickness or neurite length. These find-
ings suggested that neurofibromin might control neuronal
differentiation in a Ras-independent manner. Neurofibro-
min has been previously implicated in cAMP-dependent
nervous system development. Loss of neurofibromin in
Drosophila results in reduced growth and learning deficits
that depend on intracellular cAMP levels (Guo et al., 2000;
The et al., 1997). In addition, neurofibromin-deficientmouse
embryo forebrains exhibit decreased adenylyl cyclase
activity and lower cAMP levels (Tong et al., 2002), and
cAMP generation by pituitary adenylyl cyclase activat-
ing protein (PACAP), a regulator of cortical neuron pro-
liferation and differentiation (Lu and DiCicco-Bloom, 1997;
Ohta et al., 2006), is neurofibromin dependent (Dasgupta
et al., 2003; Guo et al., 2000).
In support of a cAMP-dependent mechanism underly-
ing neurofibromin regulation of neuronal differentiation,
we observed complete rescue of the cortical thickness
defect in CKO mice after rolipram treatment in vivo. In
addition, increasing cAMP levels in differentiating Nf1-
deficient neural progenitor cells using either rolipram or
forskolin resulted in a partial or near-complete rescue of
the CKO neurite length defect in vitro. The cAMP respon-454 Cell Stem Cell 1, 443–457, October 2007 ª2007 Elsevier Insive element binding protein (CREB) is one of the major
transcription factors driving neuronal differentiation and
neuritogenesis as well as cortical development (Chen
et al., 2005; Redmond et al., 2002). In CKOmice, we found
decreased CREB activation in the brain, reflecting re-
duced cAMP generation due to neurofibromin loss.
Previous studies have shown that cAMP-dependent
signaling is a major regulator of neuronal development
and neurite extension in vivo (Fujioka et al., 2004; Naka-
gawa et al., 2002). Our results strengthen these prior find-
ings by demonstrating a distinct role for neurofibromin
cAMP regulation in neuronal differentiation in vitro and
in vivo. Additional support for neurofibromin in neuronal
development derives from recent studies in which neuro-
fibromin was required for protein kinase A (PKA)-regulated
dendritic spine formation in cultured hippocampal neu-
rons in response to syndecan-2 (Lin et al., 2007). These
observations coupled with previous studies demonstrat-
ing a physical interaction between syndecan-2 and neuro-
fibromin (Hsueh et al., 2001) suggest that neurofibromin
cAMP regulation is an important determinant in neuronal
differentiation.
Recent findings in Nf1-deficient Drosophila mutants
have argued against separable Ras- and cAMP-related
functions (Walker et al., 2006). The findings presented in
this report support the idea that there exist distinct Ras-
and cAMP-dependent functions for neurofibromin in the
developing mammalian brain. Although there may be mi-
nor crosstalk between the cAMP-dependent pathway
and the Ras pathway, increasing cAMP levels only cor-
rected the CKO neuronal defects and Ras/Akt activation
only phenocopied the glial abnormalities seen in CKO
mice. Based on these findings, we favor a model of neuro-
fibromin-dependent brain development in which Ras ac-
tivity is largely responsible for driving gliogenesis while
neurofibromin regulation of intracellular cAMP levels is
critical for neuronal maturation and neurite extension.
This model system provides unique opportunities to study
the molecular determinants that underlie neuroglial pro-
genitor cell fate decisions essential for proper brain devel-
opment and function.
EXPERIMENTAL PROCEDURES
Generation of Transgenic Mice
A 1604 bp 50 genomic fragment of the mouse BLBP promoter was
generated by PCR, inserted upstream of a nuclear targeted Cre and
IRES-lacZ fragment, and sequenced in its entirety prior to pronuclear
injection into C57BL/6 3 CBA mice by the Washington University
Mouse Genetics Core. Transgenic mice were identified by genotyp-
ing PCR (Bajenaru et al., 2002) and successfully backcrossed with
C57BL/6 mice for at least four generations.
Mice
BLBP-Cre transgenic mice were crossed with Nf1flox/flox mice (Zhu
et al., 2001) or with Lox-stop-lox(LSL)-KRasG12D mice (Johnson
et al., 2001) to generate the BLBP-Cre; Nf1flox/flox (CKO) and BLBP-
Cre; LSL-KRasG12D (Kras*) mice, respectively. BLBP-Cre transgenic
mice were also crossed with Lox-stop-lox(LSL)-myr-Akt mice (L.E.
and E.B.-M., unpublished data) to generate the BLBP-Cre; LSL-myr-
Akt (Akt*) mice. BLBP-Cre animals were also mated with R26R-EYFPc.
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in vivo. All mice were maintained on a C57BL/6 background. BLBP-
Cre, LSL-Kras, and LSL-myr-Akt transgenes were used in heterozy-
gous contexts throughout.
X-Gal Staining
Dissected embryos were fixed by 4% paraformaldehyde (PFA) in
phosphate buffered (pH = 7.4) saline (PBS) for 1 hr prior to staining
with X-Gal (Invitrogen, Carlsbad, CA) as described previously (Baje-
naru et al., 2002).
Tissue Preparation
Timed-pregnant mothers were injected intraperitoneally with 50mg/kg
bodyweight bromodeoxyuridine (BrdU, Sigma-Aldrich, St. Louis, MO)
1 hr prior to dissection. Embryo heads were fixed overnight in 4% PFA
at 4C and then transferred into 30% sucrose for 36 hr before embed-
ding into OCT medium for snap-freezing. Brains of PN1 pups were re-
moved for overnight fixation in 4% PFA or snap-frozen. PN8 and PN18
mice were intraperitoneally injected with BrdU 1 or 3 hr prior to perfu-
sion, respectively. Mice were perfused transcardially with PBS and 4%
PFA in PBS. After overnight postfixation at 4C, coronal slices were
transferred to 70% ethanol solution prior to paraffin embedding and
sectioning.
Immunostaining
Sixteen micron cryostat sections were permeabilized with 0.1% Triton
X-100 in PBS prior to blocking and application of primary antibody. For
BrdU labeling on frozen sections, DNA was denatured by 2 M HCl for
30 min followed by two rinses of 0.1 M boric acid (pH 8.0) for 5 min at
room temperature (RT) before blocking. Five micron paraffin sections
were deparaffinized, treated for antigen retrieval, and incubated in
5% serum blocking solution prior to the overnight incubation of pri-
mary antibodies at 4C for 18 hr (Table S1). For BrdU labeling, depar-
affinized sections were treated with 0.1% trypsin in PBS for 10 min at
room temperature. DNA was denatured by 0.1 M HCl for 10 min at 4C
and 4 M HCl for 30 min at 37C followed by two rinses of 0.1 M boric
acid (pH 8.0) for 5 min at RT prior to blocking. Fluorescent detection
was performed with Alexa-labeled secondary antibodies (Molecular
Probes, Eugene, OR), whereas horseradish peroxidase-conjugated
secondary antibodies (Vector Laboratories) were employed for Vec-
tastain Elite ABC development.
High-power field (203) regions of interest on three nonconsecutive,
plane-matched sections were photographed digitally on a Nikon mi-
croscope (Melville, NY). The number of labeled nuclei (APC, BrdU,
NeuN, Olig2) or nuclei clearly associated with cytoplasmic filamentous
staining (GFAP, NG2) were counted manually with analySIS software
(Soft Imaging System Inc, Lakewood, CO). Cell counts were converted
to cell density by measuring the area of the high-power field and aver-
aged for each animal.
Golgi Staining
Perfused brains were postfixed in 4% PFA for 48 hr. Two-millimeter
coronal sections were transferred into 3%potassium dichromate solu-
tion for 5–7 days with daily changes of fresh solution. After a 1 min
wash in distilled water, slices were incubated in 2% silver nitrate solu-
tion for 3 days. Eighty micron vibrating microtome sections were air
dried on glass slides, dehydrated in ethanol and xylene, and mounted.
Embryonic Neural Stem Cell Cultures and In Vitro
Differentiation Assay
Neurospheres were established from the telencephalic lobes of E 10.5
Nf1+/+,Nf1+/, andNf1/ as well as from E 14.5 BLBP-Cre;Nf1flox/flox,
Nf1flox/flox, and BLBP-Cre; LSL-KRasG12D embryos as previously re-
ported (Dasgupta and Gutmann, 2005). Secondary neurospheres were
trypsinized, and single-cell suspensions (30,000 cells per ml) were
plated on fibronectin-coated cell culture dishes in growth media with-
out EGF and FGF. After 24 hr, cultures were treated with rolipram
(20 mM) or forskolin (20 mM). Cells were fixed after 6 days and stainedCefor Tuj1 and BLBP. The longest neurites of at least 30 randomly se-
lected Tuj1+ cells were measured for each experimental condition.
The experiments were repeated with independent cultures from at
least three embryos.
Western Blot Analysis
Brains were triturated in lysis buffer for 20 min on ice prior to centrifu-
gation at 14,000 rpm for 10 min at 4C. Equal amounts of total protein
as determined using the BCA protein assay kit (Pierce, Rockford, IL)
were separated on SDS-PAGE gel. After blocking in 5% dry milk in
Tris-buffered saline (TBS), blots were incubated overnight at 4C
with primary antibodies (Table S2) prior to peroxidase-conjugated
secondary antibody exposure and detection by Supersignal West
Pico enhanced chemiluminescence (Pierce).
cAMP Measurements
Dissected forebrain hemispheres snap-frozen in liquid nitrogen were
triturated in ice-cold 5% trichloroacetic acid (10 ml per mg tissue),
centrifuged at 10003 g for 10min at 4C. Supernatants supplemented
with equal volume of 0.1 M HCl were extracted with water-saturated
ether thrice prior to desiccation in a vacuum centrifuge. cAMP was
determined by using a cyclic AMP enzyme immunoassay kit (Assay
Designs, Ann Arbor, MI).
Rolipram Treatment
Rolipram (50 mg in 200 ml PBS with 2% DMSO) was administered to
timed-pregnant mothers from 11 days postcoitus (E11.5) until post-
natal day 18 (PN18). Pups also received daily i.p. injection of rolipram
(12.5 mg) from PN7.
Statistical Analysis
Each experiment was performed with samples from at least three
animals from independent litters. Statistical significance (p < 0.05)
was determined by unpaired t test (with Welch’s Correction) using
GraphPad Prism 4.0 software (GraphPad Inc., San Diego, CA).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online
at http://www.cellstemcell.com/cgi/content/full/1/4/443/DC1/.
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